Government & Advocacy

AMCP advocates on behalf of managed care pharmacy professionals to ensure that their interests and the patients they serve are considered in federal and state health care policy decisions.
 

Take Action

Featured Legislative & Regulatory Positions

See all Positions
A person stating at screens
Legislative & Regulatory Position

Prescription Digital Therapeutics

AMCP supports increased access to Prescription Digital Therapeutics (PDTs). PDTs are software-based therapies that deliver clinical benefits to patients, either alone or in combination with other forms of treatment. These therapeutics require a prescription and are subject to oversight by the Food and Drug Administration (FDA). To be approved by the FDA, PDTs must demonstrate both safety and efficacy.
Digital Therapeutics
Legislative & Regulatory Position

ERISA and Part D Preemption

AMCP opposes attempts to erode the Employee Retirement Income Security Act (ERISA) and Medicare Part D preemption. AMCP believes that the certainty that comes with a single uniform federal standard ensures that plans subject to these laws are better able to provide access to needed medications regardless of where the patient lives or works.
Legislation & Regulation, Medicare Part D

Featured Resources

See More Resources

Regulatory Updates

 

 

Letters, Statements, and Analysis

See All Letters, Statements, & Analysis
Letters, Statements & Analysis

AMCP, Patient and Provider Groups Applaud Supreme Court Ruling on Alliance for Hippocratic Medicine et al. v FDA et al

On June 13, AMCP joined 24 patient and provider organizations in applauding the Supreme Court's unanimous ruling reversing the Fifth Circuit's decision in Alliance for Hippocratic Medicine et al. v FDA et al. AMCP and the undersigned organizations unequivocally support FDA's role in safeguarding patients, which has yielded approval of tens of thousands of crucial medications and devices for generations of Americans.
Legislation & Regulation
Letters, Statements & Analysis

AMCP Expresses Concerns with State Legislation Restricting Managed Care Pharmacists

On May 29, AMCP released the following statement, which expresses concerns about the Illinois General Assembly's Healthcare protection Act (HB 5395). Passed on May 25, the bill restricts managed care pharmacists' ability to manage prescription drug benefits for millions of Illinoisans covered under the state’s Medicaid program, state employee group insurance, and fully insured commercial plans.
Legislation & Regulation
Letters, Statements & Analysis

AMCP Comment Letter on MPPP Model Documents

On Feb. 29, 2024, the Centers for Medicare and Medicaid Services (CMS) issued The Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents. AMCP submitted comments in response to this Model Documents on April 29, 2024.
Legislation & Regulation

Take Action

Grassroots Advocacy

AMCP represents managed care pharmacy in meetings with federal lawmakers and regulators and submits comments on proposed rules and regulations. We need and urge your participation in this process through our grassroots advocacy program.

Take Action Now